| Literature DB >> 34223048 |
David McMaster1, Molly Courtenay2, Catherine Santucci3, Angharad P Davies4, Andrew Kirby5, Owen Seddon6, David A Price7, Gavin Barlow8, Felicia H Lim9, Bethany S Davies10, Matthew K O'Shea11, Paul Collini12, Marina Basarab13, Afshan Ahmad14, Mahableshwar Albur15, Carolyn Hemsley16, Nicholas M Brown17, Ciaran O'Gorman18, Riina Rautemaa-Richardson19, Geraint R Davies20, Christopher N Penfold21, Sanjay Patel22.
Abstract
BACKGROUND: In the UK there is limited coverage of antimicrobial stewardship across postgraduate curricula and evidence that final year medical students have insufficient and inconsistent antimicrobial stewardship teaching. A national undergraduate curriculum for antimicrobial resistance and stewardship is required to standardize an adequate level of understanding for all future doctors.Entities:
Year: 2020 PMID: 34223048 PMCID: PMC8210211 DOI: 10.1093/jacamr/dlaa096
Source DB: PubMed Journal: JAC Antimicrob Resist ISSN: 2632-1823
Round one responses
| Competency descriptors | Median | IQR |
|---|---|---|
| Domain 1: Infection prevention and control | ||
| 1.1 Describing the nature and classification of pathogenic microorganisms | 5 | 1 |
| 1.2 Describing how microorganisms cause infections in humans: the importance of understanding the differences between colonization (e.g. of venous leg ulceration) and infection | 6 | 1 |
| 1.3 Explaining what an antimicrobial resistant organism is | 6 | 1 |
| 1.4 Explaining the ‘Chain of Infection’ | 5 | 2 |
| 1.5 How microorganisms are transmitted in both community and hospital settings | 5 | 1 |
| 1.6 Defining the components required for infection transmission (i.e. presence of an organism, route of transmission of the organism from one person to another, a host who is susceptible to infection) | 5 | 1 |
| 1.7 Describing the routes of transmission of infectious organisms (i.e. contact, droplet, airborne routes) | 6 | 1 |
| 1.8 Present and recognize the characteristics of a susceptible host | 5 | 1 |
| 1.9 Demonstrating an understanding of the importance of screening for infections (e.g. MRSA on admission to hospital, carbapenem resistance for patients with risk factors) | 5 | 2 |
| 1.10 Demonstrate the application of standard precautions in healthcare environments | 6 | 1 |
| 1.11 Apply appropriate policies/procedures and guidelines when collecting and handling specimens | 5 | 1 |
| 1.12 Apply policies, procedures and guidelines relevant to infection control when presented with infection control cases and situations | 5 | 1.25 |
| 1.13 Implement work practices that reduce risk of infection (such as taking appropriate immunization or not coming to work when sick to ensure patient and other healthcare worker protection) | 6 | 1 |
| 1.14 Appreciate that healthcare workers have the accountability and obligation to follow infection control protocols as part of their contract of employment | 6 | 1 |
| 1.15 Act as a role model to healthcare workers and members of the public by adhering to infection prevention and control principles | 6 | 1 |
| 1.16 Demonstrating knowledge and awareness of international/national strategies on infection prevention and control and antimicrobial resistance (e.g. Global Action Plan for AMR; WHO SAVE LIVES: Clean Your Hands; UK Government 5-year AMR strategy) | 4 | 2 |
| Domain 2: Antimicrobials and antimicrobial resistance | ||
| 2.1 Describe the modes of action of antibiotics and other antimicrobials | 4.5 | 2 |
| 2.2 Describe the spectrum of activity for commonly prescribed antimicrobials | 5 | 1 |
| 2.3 Describe broad spectrum and narrow spectrum antimicrobials and the contribution of broad-spectrum antimicrobials to antimicrobial resistance | 6 | 1 |
| 2.4 Describe the mechanisms of antimicrobial resistance, including: intrinsic or acquired resistance; the importance of selection advantages (e.g. the greater ability for some to colonize) and how this can be an amplification process for antimicrobial resistance | 4 | 1 |
| Domain 3: Antimicrobial prescribing and stewardship | ||
| 3.1 Demonstrate an appreciation that appropriate use of antimicrobials reduces the emergence of resistance and reduces adverse effects (e.g. their disruptive effects on host normal flora, which may lead to, for example, | 6 | 1 |
| 3.2 Demonstrate an understanding of the key elements of prescribing an antimicrobial, including: obtaining microbiological cultures or other relevant tests before commencing treatment as necessary; the choice of agent; the route of administration; its pharmacokinetics and how this affects the choice of dosage regimen; how to monitor levels and adjust doses (e.g. in the elderly or renal impairment); where to seek specialist advice; decisions to switch agent (e.g. from intravenous to oral, narrower to broader spectrum [or vice versa]) base on microbiological results; the duration of treatment and when to consider review/stop dates | 6 | 0 |
| 3.3 Recognize the importance of initiating prompt effective empirical antimicrobial treatment in patients with life-threatening infections (sepsis) | 6 | 0 |
| 3.4 Understand why self-limiting bacterial or viral infections are unlikely to benefit from antimicrobials | 6 | 1 |
| 3.5 Understand how inflammatory markers and other investigations are used to diagnose and monitor the response to treatment of infections and their complications | 5 | 1 |
| 3.6 Describe and demonstrate how to select the appropriate antimicrobial, paying due consideration to local guidance, how, and where, to access this | 6 | 1 |
| 3.7 Understand how local microbial/antimicrobial susceptibility patterns impacts on the choice of empirical therapy | 5 | 2 |
| 3.8 Demonstrate an understanding of patient specific factors that need to be considered when choosing an antimicrobial which may influence the choice of antimicrobial (i.e. know colonization with resistant organisms) | 6 | 1 |
| 3.9 Demonstrate an understanding of how to interpret microbiology results/reports from the laboratory | 5 | 1 |
| 3.10 Describe and demonstrate switching to the correct antimicrobial when susceptibility testing indicates resistance, or to a cheaper or more cost-effective antimicrobial that is also compatible with the clinical presentation | 6 | 1 |
| 3.11 Describe the common side-effects, including allergy, drug/food interactions, contraindications of the main classes of antimicrobials, and the importance of monitoring for these, and what to do when these are suspected | 6 | 1 |
| 3.12 Demonstrate knowledge of when not to prescribe antimicrobials, and use of alternatives, such as the removal of invasive devices (e.g. intravenous or urinary catheters and incision and drainage of abscesses [source control]) | 6 | 0.25 |
| 3.13 Demonstrate an understanding of the rationale and use of perioperative prophylactic antimicrobials to prevent surgical site infection | 5 | 1 |
| 3.14 Demonstrate an understanding of why accurately documenting a patient allergy to an antimicrobial is important | 6 | 0.25 |
| 3.15 Demonstrate the importance of documenting in the prescription chart and/or in patients’ clinical records, the clinical indication, route, dose, duration and review date of antimicrobials | 6 | 0.25 |
| 3.16 Demonstrate knowledge of when to use a delayed antimicrobial prescription and how to negotiate this with the patient | 5 | 2 |
| 3.17 Demonstrate the review of antimicrobial prescriptions for hospital inpatients on all ward rounds. Appropriately choosing one of the five antimicrobial prescribing decisions 48 h after initiating antimicrobial treatment (ARHAI Guidance—Start Smart—then Focus) | 6 | 1 |
| a. Stop antibiotics if there is no evidence of infection | ||
| b. Switch antibiotics from intravenous to oral administration | ||
| c. Change antibiotics—ideally to a narrower spectrum (or broader if required) | ||
| d. Continue and review again at 72 h | ||
| e. Outpatient Parenteral Antibiotic Therapy (OPAT) | ||
| 3.18 Educate patients and their carers, nurses and other supporting clinical staff as to when antibiotics are not required and complying with the duration and frequency of administration of their prescribed antimicrobial | 5 | 1.25 |
| Domain 4: Vaccine uptake | ||
| 4.1 Able to discuss the relevant national and local immunization programmes and the diseases for which vaccines are currently available. Aware of programmes for specific clinical risk groups and use of vaccination in outbreak situations | 5 | 1 |
| 4.2 Able to explain the general principles of immunization (e.g. why multiple and/or booster doses are required, why intervals need to be observed between doses and why the influenza vaccine needs to be given annually) | 5 | 0.25 |
| 4.3 Able to clearly and confidently discuss the risks and benefits of vaccination and able to address any concerns patients and/or parents/carers may have | 5 | 1 |
| 4.4 Aware of, and able to discuss, any current issues, controversies or misconceptions surrounding immunization | 5 | 1 |
| 4.5 Understand how current vaccines can benefit prescribing practices, including reducing the need for prescribing antimicrobials and decreasing antimicrobial-resistant strains (e.g. of | 5 | 2 |
| 4.6 Aware of local and national targets for immunization uptake and why vaccine uptake data is important. If appropriate, know where to find data for their area of practice | 4 | 1 |
| Domain 5: Person-centred care | ||
| 5.1 Support participation of patients/carers, as integral partners when planning/delivering their care | 5.5 | 1 |
| 5.2 Share information with patients/carer in a respectful manner and in such a way that is understandable, encourages discussion, and enhances participation in decision-making | 6 | 1 |
| 5.3 Ensure that appropriate education and support is provided by learners to patients/carer, and others involved with their care or service | 5 | 1 |
| 5.4 Listen respectfully to the expressed needs of all parties in shaping and delivering care or services | 5 | 2 |
| 5.5 Discuss patient/carer expectations or demands of antimicrobials and the need to use antimicrobials appropriately | 6 | 1 |
| Domain 6: Interprofessional collaborative practice | ||
| 6.1 Demonstrate an understanding of the roles, responsibilities, and competencies of other health professionals involved in antimicrobial treatment policy decisions | 5 | 2 |
| 6.2 Explain why it is important that healthcare professionals, involved in the delivery of antimicrobial therapy (including the prescription, delivery and supply) have a common understanding of antimicrobial treatment policy decisions, the quantity of antimicrobial use, and effective patient/client outcomes | 5 | 1.25 |
| 6.3 Establish collaborative communication principles and actively listen to other professionals and patients/carer involved in the delivery of antimicrobial therapy | 5 | 1.25 |
| 6.4 Communicate effectively to ensure common understanding of care decisions | 5 | 1 |
| 6.5 Develop trusting relationships with patients/carer and other health/social care professionals | 5 | 1.25 |
| 6.6 Effectively use information and communication technology to improve interprofessional patient-centred care | 5 | 2 |
Experts ranked descriptors split into six domains on a six-point Likert scale (1 = strongly disagree; 6 = strongly agree) during the first round of a modified Delphi method questionnaire. Medians and IQRs of responses were calculated.
Descriptors viewed as less important, i.e. median <5 (on a six-point Likert scale).
Lack of agreement between experts, i.e. IQR >1.5.
Round two responses
| New descriptors | Median | IQR |
|---|---|---|
| Domain 1: Infection prevention and control | ||
| Aware of which vaccinations healthcare workers should receive in addition to standard UK immunizations | 5 | 1 |
| Describe what is meant by contact precautions, droplet precautions and airborne precautions | 6 | 1 |
| Awareness of the cost (e.g. to the patient, society, healthcare system) of hospital acquired infections | 5 | 2 |
| Understand how to use PPE and when to apply to appropriate situations | 6 | 1 |
| Domain 2: Antimicrobials and antimicrobial resistance | ||
| Describe the implications of commonly encountered resistance profiles in terms of patient management (e.g. MRSA, VRE, ESBL, CPE) | 5 | 1 |
| Awareness of factors contributing to AMR including inappropriate prescribing by healthcare workers and the sale of antimicrobials without prescription (e.g. over the counter in some parts of the world; online sales) | 5 | 1 |
| Understand the link between antimicrobials and the human microbiome and how this facilitates spread of resistant organisms | 5 | 2 |
| Aware of which vaccinations healthcare workers should receive in addition to standard UK immunizations | 4 | 1 |
| Domain 3: Antimicrobial prescribing and stewardship | ||
| Describe key features of specific infections and the best narrow spectrum antibiotics to prescribe and length of antibiotic course in these scenarios (e.g. UTI, pneumonia, cellulitis) | 6 | 1 |
| Understand how to request and interpret basic diagnostic tests that can guide antimicrobial therapy (e.g. microbiology, radiology, immunology) | 6 | 0.25 |
| Domain 4: Vaccine uptake | ||
| Knowledge of different types of vaccine and different vaccine development strategies | 4 | 1 |
| Understand cultural sensitivities around refusal to take vaccines | 5 | 1 |
|
| ||
| Round one descriptors | Median | IQR |
|
| ||
| Domain 1: Infection prevention and control | ||
| 1.4 Explain the ‘Chain of Infection’ | 5 | 1 |
| 1.16 Demonstrating knowledge and awareness of international/national strategies on infection prevention and control and antimicrobial resistance (e.g. Global Action Plan for AMR; WHO SAVE LIVES: Clean Your Hands; UK Government 5-year AMR strategy) | 4 | 1 |
| 1.9R Demonstrate an understanding of the principles of why screening for infections (e.g. MRSA on admission to hospital) is important for reducing nosocomial spread | 5.5 | 1 |
| Domain 2: Antimicrobials and antimicrobial resistance | ||
| 2.1R Demonstrate an understanding of the spectrum of antibiotic activity in terms of Gram-positive, Gram-negative, anaerobic and atypical organisms. | 6 | 1 |
| Domain 3: Antimicrobial prescribing and stewardship | ||
| 3.7 Understand how local microbial/antimicrobial susceptibility patterns impacts on the choice of empirical therapy | 5 | 1 |
| 3.16 Demonstrate knowledge of when to use a delayed antimicrobial prescription and how to negotiate this with the patient | 5 | 1 |
| 3.18R Demonstrate the ability to educate patients and their carers, nurses and other supporting clinical staff about when antibiotics are and are not required, the importance of complying with the duration/frequency of administration of their prescribed antimicrobial and when to seek help | 6 | 1 |
| Domain 4: Vaccine uptake | ||
| 4.5 Understand how current vaccines can benefit prescribing practices, including reducing the need for prescribing antimicrobials and decreasing antimicrobial-resistant strains (e.g. of | 5 | 2 |
| Domain 5: Person-centred care | ||
| 5.4 Listen respectfully to the expressed needs of all parties in shaping and delivering care or services | 5.5 | 1 |
| Domain 6: Interprofessional collaborative practice | ||
| 6.1 Demonstrate an understanding of the roles, responsibilities, and competencies of other health professionals involved in antimicrobial treatment policy decisions | 5 | 1 |
| 6.6 Effectively use information and communication technology to improve interprofessional patient-centred care | 5 | 2 |
| 6.2R Explain why it is important that healthcare professionals involved in the delivery of antimicrobial therapy (including the prescription, delivery and supply) have a common understanding of antimicrobial treatment policy decisions, the quantity/quality of antimicrobial use, and effective patient/client outcomes | 5 | 1.25 |
Experts ranked descriptors split into six domains on a six-point Likert scale (1 = strongly disagree; 6 = strongly agree) during the second round of a modified Delphi method questionnaire. The second-round questionnaire included 12 new descriptors, 4 amended round-one descriptors (R) and 12 round-one descriptors with disagreement. Medians and IQRs of responses were calculated.
PPE, personal protective equipment.
Descriptors viewed as less important, i.e. median <5 (on a six-point Likert scale).
Lack of agreement between experts, i.e. IQR >1.5.